Literature DB >> 9194220

Fas and other cell death signaling pathways.

V Depraetere1, P Golstein.   

Abstract

The Fas system ensures, within the immune system, one of the two main pathways of T-cell mediated cytotoxicity, and, importantly, at least part of the downregulation of immune responses. Recently, Fas has been increasingly implicated in other functions, such as protection of immune privileged tissues and disposal of cells undergoing genomic alterations. The Fas system can be viewed as a cell death signal, linking extracellular information to the cell death execution stage. In this review, the Fas pathway will be described, compared to the other known T-cell mediated cytotoxicity mechanism, and then more generally to other cell death signals. The general features of cell death signaling will be emphasized as well as the peculiarities of the Fas system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194220     DOI: 10.1006/smim.1997.0062

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  16 in total

1.  FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells.

Authors:  Zhen Sun; Zhong-Yuan Wan; Yun-Shan Guo; Hai-Qiang Wang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

2.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 3.  New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease.

Authors:  Xinghui Sun; Edward N Harris
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

4.  Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB.

Authors:  N J Pazdernik; D B Donner; M G Goebl; M A Harrington
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction.

Authors:  Khadija Iken; Lin Huang; Hewan Bekele; Emmett V Schmidt; Margaret James Koziel
Journal:  Virology       Date:  2005-12-05       Impact factor: 3.616

6.  High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression.

Authors:  C Yin; M S Wu; C D Pauza; M S Salvato
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.

Authors:  Y Zhai; R Guo; T L Hsu; G L Yu; J Ni; B S Kwon; G W Jiang; J Lu; J Tan; M Ugustus; K Carter; L Rojas; F Zhu; C Lincoln; G Endress; L Xing; S Wang; K O Oh; R Gentz; S Ruben; M E Lippman; S L Hsieh; D Yang
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

8.  Fas and Fas-ligand expression in human pancreatic cancer.

Authors:  M Kornmann; T Ishiwata; J Kleeff; H G Beger; M Korc
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

9.  Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds.

Authors:  Jürg Gertsch; Martin Güttinger; Otto Sticher; Jörg Heilmann
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

10.  Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.

Authors:  Irina Bonzheim; Eva Geissinger; Wen-Yu Chuang; Sabine Roth; Philipp Ströbel; Alexander Marx; Peter Reimer; Martin Wilhelm; Bernhard Puppe; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Hematop       Date:  2008-04-24       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.